-
Maxygen Inc. was a
biopharmaceutical company focused on
developing improved versions of
protein drugs using DNA
shuffling and
other protein modification...
-
acquired by
Maxygen in 2000, for $60
million in stock. From its
acquisition by
Maxygen until 2008, the
company continued as a
subsidiary of
Maxygen forming...
- –
Maxygen, Inc.
Maxygen, Inc.
Raises $110
Million In
Initial Public Offering of Its
Common Stock DuPont To
Acquire Maxygen Subsidiary Verdia Maxygen Announces...
- 2017)
Martek (1985–2011) M****one (company) (????- )
Mayne (2005–2007)
Maxygen (1997–2013)
Medarex (1987–2009) Meda (1995–2016)
MedImmune (1988–2019)...
- LPL
Financial LSI
Corporation Mad Catz
Malibu Boats Matson, Inc.
Maxtor Maxygen Memorex Mervyn's
Metropolitan West
Financial MicroPower Technologies Microsoft...
- 2002. It went
public in
April 2010 on NASDAQ, and in October,
acquired Maxygen's MolecularBreeding technology portfolio.
Codexis won the
Presidential Green...
- DNA
shuffling (also
known as "molecular breeding"). In 1997 he
founded Maxygen to
commercialize DNA shuffling,
which led to the
founding of both Verdia...
-
combinatorial chemistry technologies.
Other companies he
founded include Maxygen (1997), a
developer of
technologies that
improve the
development of proteins...
-
Silicon Valley high
technology companies,
including Flextronics, Magma,
Maxygen,
Monogram Biosciences,
Silicon ****e, Symyx, and Syrrx.
While at Presidio...
- Møller Mikkelsen, and
remained co-CEO
thereof until its
acquisition by
Maxygen in 2000. In 2001, he co-founded the
investment firm
Nordic Biotech Advisors...
